Intravenous Infusions Limited (IIL.gh) 2022 Annual Report

Intravenous Infusions Limited (IIL.gh) listed on the Ghana Stock Exchange under the Pharmaceuticals sector has released it’s 2022 annual report.

For more information about Intravenous Infusions Limited (IIL.gh) reports, abridged reports, interim earnings results and earnings presentations visit the Intravenous Infusions Limited (IIL.gh) company page on AfricanFinancials.

Indicative Share Trading Liquidity

The total indicative share trading liquidity for Intravenous Infusions Limited (IIL.gh) in the past 12 months, as of 3rd November 2022, is US$4.98K (GHS37.92K). An average of US$415 (GHS3.16K) per month.

Intravenous Infusions Limited 2022 annual report

Company Profile

Intravenous Infusions Limited is making waves on the Ghana Stock Exchange. The healthcare and medical services provider specializes in providing vital medical facilities in Ghana’s capital Accra. The company was founded three years ago, relying on their competent and experienced personnel to deliver professional and advanced treatments to patients. Driven by innovation, Intravenous Infusions Limited is setting a benchmark in the country’s healthcare sector. They offer a wide range of services, ranging from general inpatient care, surgery, laboratory services, imaging, and more. In addition, they are also renowned for their commitment to providing superior quality care to their patients. The company has managed to grow significantly and is now a trusted partner to numerous medical organizations and hospitals, offering them the latest technology and helping them stay up to date with the latest trends and developments. Perhaps most impressive of all is their financial performance. Intravenous Infusions Limited has managed to grow their shares by 15% year-on-year since listing, making them a great pick for investors with a long-term view.